Generic Lipitor recall hits Ranbaxy profitsRavi Ananthanarayanan
On Friday, Ranbaxy posted a notice on its U.S. website, saying it's recalling 10-, 20- and 40-milligram doses of tablets of atorvastatin calcium. That's generic Lipitor, the cholesterol fighter that reigned for years as the world's top-selling drug. The recall includes 41 lots of th...
(CBSNews) – Ranbaxy Pharmaceuticals Inc. is recalling more than 40 lots of atorvastatin pills -- the generic version of the popular statin Lipitor -- over possible glass contamination. Statins, or lipid-lowering drugs, are among the most commonly prescribed medications in the United States. The...
Received ANDA Tentative Approval for Lacosamide Tablets, 50 mg, 100 mg, 150 mg, and 200 mg Sciegen Metformin product – not part of Recall Sciegen Pharmaceuticals Inc states that the Immediate release tablets Metformin Hydrochloride Tablets, USP 500 mg, 850 mg & 1000 mg manufactured by Sciegen ...
or other precautions may be necessary. When you are irresistible this medicine, it is uniquely worthy that your healthcare professional recall if you are alluring any of the medicines listed below. The following interactions from been selected on the basis of their potential significance and are no...
Ropinirole usp monograph of clopidogrel Cabg clopidogrel generic Clopidogrel intermediates in chemistry Duration of clopidogrel therapyappointment Lopid de 600 mg Clopidogrel platelet function test Clopidogrel xrd machine Lopid 450 mg Lipitor plus lopid ...
The article reports that pharmaceutical company Ranbaxy Laboratories Ltd.'s investigation into a recall of its generic version of the cholesterol treatment drug Lipitor after glass fragments were found in the drug revealed that a faulty glass tank used in production was responsible.Rockoff...
Ranbaxy Calls Back Lots of Generic Lipitor Due to Glass Particles.The article focuses on the drug recall initiated by Ranbaxy Inc. due to the small glass particles that contaminate the generic form of their cholesterol drug Lipitor.EBSCO_bspChain Drug Review...